Publication Date:
2017-04-06
Description:
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML Leukemia 31, 829 (April 2017). doi:10.1038/leu.2017.9 Authors: C Schütz, S Inselmann, S Sausslele, C T Dietz, M C Müller, E Eigendorff, C A Brendel, S K Metzelder, T H Brümmendorf, C Waller, J Dengler, M E Goebeler, R Herbst, G Freunek, S Hanzel, T Illmer, Y Wang, T Lange, F Finkernagel, R Hehlmann, M Huber, A Neubauer, A Hochhaus, J Guilhot, F Xavier Mahon, M Pfirrmann & A Burchert
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink